Abstract # 2303
A Pretreatment PSA Level of 7 to 10 Ng/ml is an Independent Predictor of Adverse Biochemical Disease Free Survival among Low Risk Prostate Cancer Patients Treated with I-125 Brachytherapy
< Back to topics
Cover Page, Authors, Institutions
No tables, images, or additional files are available for this abstract.
Copyright © 2008,
American Society for Therapeutic Radiology and Oncology
12500 Fair Lakes Circle Suite #375, Fairfax, VA 22033-3882 | Phone: 703.502.1550 or 800.962.7876 Fax: 703.502.7852